[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60233353D1 - Verfahren zur behandlung von halitose - Google Patents

Verfahren zur behandlung von halitose

Info

Publication number
DE60233353D1
DE60233353D1 DE60233353T DE60233353T DE60233353D1 DE 60233353 D1 DE60233353 D1 DE 60233353D1 DE 60233353 T DE60233353 T DE 60233353T DE 60233353 T DE60233353 T DE 60233353T DE 60233353 D1 DE60233353 D1 DE 60233353D1
Authority
DE
Germany
Prior art keywords
halitosis
treatment
vertebrate
bismuth
sulfite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233353T
Other languages
English (en)
Inventor
Terry Dorcen Bolin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60233353D1 publication Critical patent/DE60233353D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60233353T 2001-11-28 2002-11-27 Verfahren zur behandlung von halitose Expired - Lifetime DE60233353D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR9161A AUPR916101A0 (en) 2001-11-28 2001-11-28 Method of treating halitosis
PCT/AU2002/001604 WO2003045403A1 (en) 2001-11-28 2002-11-27 Method of treating halitosis

Publications (1)

Publication Number Publication Date
DE60233353D1 true DE60233353D1 (de) 2009-09-24

Family

ID=3832971

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233353T Expired - Lifetime DE60233353D1 (de) 2001-11-28 2002-11-27 Verfahren zur behandlung von halitose

Country Status (7)

Country Link
US (1) US20050053556A1 (de)
EP (1) EP1469867B1 (de)
AT (1) ATE439136T1 (de)
AU (1) AUPR916101A0 (de)
DE (1) DE60233353D1 (de)
NZ (1) NZ533677A (de)
WO (1) WO2003045403A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544204B2 (en) * 2003-10-15 2009-06-09 Valam Corporation Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
CN114984254B (zh) * 2022-06-08 2023-06-27 上海交通大学医学院附属第九人民医院 一种光声成像造影剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6372784B1 (en) * 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) * 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
AU5439696A (en) 1995-08-24 1997-03-19 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
NZ581806A (en) * 2004-06-07 2011-10-28 Qu Biolog Inc Bacterial compositions for the treatment of cancer

Also Published As

Publication number Publication date
EP1469867A1 (de) 2004-10-27
EP1469867B1 (de) 2009-08-12
EP1469867A4 (de) 2005-10-05
US20050053556A1 (en) 2005-03-10
AUPR916101A0 (en) 2001-12-20
ATE439136T1 (de) 2009-08-15
NZ533677A (en) 2006-07-28
WO2003045403A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
DE60335997D1 (de) Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
DE60143549D1 (de) Verwendung von Botulinum Toxin zur Behandlung von durch Infektion verursachtem Schmerz
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE377657T1 (de) Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE69902154D1 (de) Eisen-dextran verbindung zur verwendung als komponente in einer therapeutischen zusammensetzung zur behandlung oder prophylaxe von eisenmangel, sowie verfahren zur herstellung der eisen-dextran verbindung und ihre anwendung zur herstellung einer parenteral anwendbaren therapeutischen zubereitung.
DE60114439D1 (de) Verfahren zur antimikrobiellen behandlung von fasermaterialien
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE60233353D1 (de) Verfahren zur behandlung von halitose
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten
ATE203162T1 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE354361T1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
DE69504717D1 (de) Behandlung von organischen Verbindungen zur Reduzierung des Chlorgehaltes
ATE372119T1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum

Legal Events

Date Code Title Description
8364 No opposition during term of opposition